33
Views
29
CrossRef citations to date
0
Altmetric
Article

Does the ‘test‐and‐treat’ strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two‐year follow‐up study of 1552 patients

, , , &
Pages 327-335 | Received 18 Aug 2003, Accepted 29 Nov 2003, Published online: 08 Jul 2009

References

  • Hession PT, Malagelada J. Review article: The initial management of uninvestigated dyspepsia in younger patients—the value of symptom-guided strategies should be reconsidered. Aliment Pharmacol Ther 2000;14:379–88.
  • Gisbert JP, Pajares JM. Helicobacter pylori ‘test-and-treat’ strategy for dyspeptic patients. Scand J Gastroenterol 1999;34:644–52.
  • Fennerty MB. Review article: Helicobacter pylori and uninvestigated dyspepsia. Aliment Pharmacol Ther 2002;16 Suppl 1:52–7.
  • Malfertheiner P, Megraud F, O’Morain C, Hungin APS, Axon A, Graham DY, et al. Current concepts in the management of Helicobacter pylori infection: The Maastricht 2–2000 Consensus Report. Aliment Pharmacol Ther 2002;16: 167–80.
  • Agréus L, Engstrand K, Svärdsudd K, Nyren O, Tibblin G. Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms. Scand J Gastroenterol 1995;30:752–7.
  • Bernersen B, Johnsen R, Bostad L, Straume B, Sommer A-I, Burhol PG. Is Helicobacter the cause of dyspepsia? Br Med J 1992;304:1276–9.
  • McColl KEL, El-Nujumi A, Murray L, El-Omar E, Gillen D, Dickson A, et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997;40:302–6.
  • Bytzer P. How should new-onset dyspepsia be managed in general and specialist practice? Baillière’s Clin Gastroenterol 1998;12:587–600.
  • Heaney A, Collins JSA, Watson RGP, McFarland RJ, Bamford KB, Tham TCK. A prospective randomised trial of a test-and-treat policy versus endoscopy based management in young Helicobacter positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut 1999;45:186–90.
  • Lassen AT, Pedersen FM, Bytzer P, Schaffalitzky de Mukadell OB. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000;356: 455–60.
  • McColl KEL, Murray LS, Gillen D, Walker A, Wirz A, Fletcher J, et al. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia. Br Med J 2002;324:999–1002.
  • Sonnenberg A. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic patients. Am J Gastroenterol 1996;91:1173–7.
  • Silverstein M, Pettersson T, Talley N. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996;110: 72–83.
  • Ofman J, Etchason J, Fullerton S, Kahn KL, Soll AH. Management strategies for Helicobacter pylori—seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med 1997;126: 280–91.
  • Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treating Helicobacter pylori infection in primary health care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment—Helicobacter pylori positive (CADET-Hp) randomised controlled trial. Br Med J 2002;324:1012–16.
  • Talley NJ, Axon A, Bytzer P, Veldhyzen vand den Zanten S. Management of uninvestigated and functional dyspepsia: a working party report for the World Congress ofGastroenterology 1998. Aliment Pharmacol Ther 1999;13: 1135–48.
  • Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Br Med J 2000;321:659–64.
  • Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdorffer E, O’Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter 1996;1: 138–44.
  • Koivisto T, Färkkilä M, Niemelä S, Rautelin HI, Pikkarainen PI, Sipponen PI. Prevalence of Helicobacter pylori metronidazole and claritromycin resistance in Finland: associated factors. Gastroenterology 2002;122 Suppl 1:A9.
  • Bayerdorffer E, Lind T, Dite P, Bardhan KD, O’Morain C, Delhier JC, et al. Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection. Eur J Gastroenterol 1999;11 Suppl 2:S19–22.
  • Bell GD, Powell KU, Burridge SM, Bowden AN, Rameh B, Bolton G, et al. Helicobacter pylori eradication: efficacy and side effects profile—a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. Q J Med 1993;86:743–50.
  • Gisbert JP, Marcos S, Gisbert JL, Pajares JM. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. Eur J Gastroenterol Hepatol 2001;13:1303–7.
  • Delaney BC, Wilson S, A Roalfe A, Roberts L, Redman V, Wearn A, et al. Cost effectiveness of initial endoscopy for dyspepsia in patients over 50 years: a randomised controlled trial in primary care. Lancet 2000;356:1965–9.
  • Moayyaedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon ATR. Helicobacter eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease: a randomised controlled trial. Gastroenterology 2001;121:1120–6.
  • Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G. Helicobacter pylori and symptomatic relapse of gastroesophageal reflux disease: a randomised controlled trial. Lancet 2001;357:1738–42.
  • Moayyaedi P, Feltbower R, Brown J, Mason S, Mason J, Nathan Richards ID, et al. Effect of population based screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000;355: 1665–9.
  • Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442–7.
  • Hamada H, Haruma K, Mihara M, Kamada T, Yoshihara M, Sumii K, et al. High incidence of reflux esophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 2000; 14:729–35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.